Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same

Multispecific antibodies

Antibodies specific for FLT3 and their uses

ADAM6 mice

ADAM6 mice

Human monoclonal antibodies to ganglioside GD2

ANTI-OX40 ANTIBODIES AND THEIR USES

ANTIGEN-BINDING MOLECULE AND USES THEREOF

Anti-mesothelin antibody and composition comprising the same

Human monoclonal anti-PD-L1 antibodies and methods of use

Antibodies against human CSF-1R and uses thereof

Antibodies to canine interleukin-4 receptor alpha

Human anti-VEGFR-2/KDR antibodies

Anti-PD-L1 antibodies and uses thereof

Anti-PD-L1 antibodies and uses thereof

Caninized murine antibodies to human PD-1

Anti-PD-1 antibodies and therapeutic uses thereof

Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)

ANTIBODY MOLECULES WHICH BIND IL-17A AND IL-17F

Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof

Human antibodies to Bet v 1 and methods of use thereof

Methods and compositions relating to chimeric antigen receptors

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

ADAM6 mice

Compositions and methods for making antibody conjugates

HUMANIZED PAN-HER ANTIBODY COMPOSITIONS

Anti-pro/latent-Myostatin antibodies and uses thereof

Compositions with improved intravitreal half-life and uses thereof

Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity

HUMAN ANTIBODIES TO GFR ALPHA 3 AND METHODS OF USE THEREOF

ROR1 antibody compositions and related methods

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

Antibodies for IL-17C

Biopharmaceutical compositions and related methods

Conditionally active chimeric antigen receptors for modified T-cells

Antibodies, pharmaceutical compositions and methods

Anti-OX40 antibody and application thereof

FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)

Thrombin-binding antibody molecules and uses thereof

Thrombin-binding antibody molecules and uses thereof

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

PD-L1 antibody, antigen-binding fragment thereof and medical application thereof

ICOS BINDING PROTEINS

BTLA agonist antibodies and uses thereof

Method for treating lupus by administering an anti-IL-12 antibody

Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)

Complement factor D antagonist antibodies and conjugates thereof

Recombinant antibodies that recognize the C-terminal domains of Ebola virus nucleoprotein

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

Antibodies comprising modified heavy constant regions

Separating agent for human serum-derived IgG polyclonal antibodies, and method for separating human serum-derived IgG polyclonal antibodies using same

Targeted self-assembly of functionalized carbon nanotubes on tumors

Anti-garp antibody

Glycan-interacting compounds and methods of use

MSLN targeting trispecific proteins and methods of use

ANTAGONIST ANTI-IL-7 RECEPTOR ANTIBODIES AND METHODS

BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)

Tumor-specific anti-EGFR antibody and application thereof

Anti-MET antibodies and compositions

ANTI- NKG2D SINGLE DOMAIN ANTIBODIES AND USES THEREOF

Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers

Single domain antibody and derivative proteins thereof against programmed death-ligand (PDL1)

Anti-CD79b antibodies and methods of use

Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules

GARP-TGF-beta 1 antibodies

Nucleic acids encoding anti-Factor P antibodies

HUMANIZED ANTIBODY

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HCMV

Synthetic single domain antibody

Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof

Bispecific antibodies specifically binding to PD1 and LAG3

Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof

Method for identifying antigen-specific T cell receptors in primate

Antibodies to ticagrelor and methods of use

Antibody Fc mutants with ablated effector functions

Anti-CD3-folate conjugates and their uses

T cell receptors and immune therapy using the same

Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies

Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof

Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Anti-nodal antibodies and methods of using same

Antibodies against infectious diseases

Methods to create chemically-induced dimerizing protein systems for regulation of cellular events

Method for mass humanization of rabbit antibodies

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

Anti-DLL3 antibody drug conjugates for treating cancer

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies

Antibodies specific for IL-21 and uses thereof

Bispecific antibody-mediated cancer therapy with cytokine-induced killer cell

Binding molecules that inhibit cancer growth

Use of anti-endoglin antibodies for treating ocular fibrosis

Anti-TNFRSF25 antibodies

Human TNFRSF25 antibody

Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses

IL3Rα antibody conjugates and uses thereof

Anti-EGFRvIII antibodies and uses thereof

Anti-integrin β1 antibody compositions and methods of use thereof

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Humanized antigen-binding domains and methods of use

Anti-SIRPα antibodies

Anti-CD33 antibodies and immunoconjugates

ANTI-IL-17A AND IL-17F CROSS REACTIVE ANTIBODY VARIANTS AND COMPOSITIONS COMPRISING AND METHODS OF MAKING AND USING SAME

ANTI RSPO ANTIBODIES AND METHODS OF USE

Anti-age antibodies and methods of use thereof

ANTIBODIES TARGETING A MANNAN-BASED O-ANTIGEN OF K. PNEUMONIAE

ANTIBODIES AGAINST INFLUENZA VIRUS AND METHODS OF USE THEREOF

Antibody-mediated neutralization of Marburg virus

Nucleic acid encoding dual Fc antigen binding proteins

Anti-TPBG antibodies and methods of use

Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition

Anti-VISTA antibodies and fragments

Methods for producing fabs and bi-specific antibodies

PDL-1 antibody, pharmaceutical composition thereof, and uses thereof

Immunoglobulin-binding proteins and their use in affinity purification

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

Agent, uses and methods for treatment

HIDE1 COMPOSITIONS AND METHODS

Anti-PAR2 antibodies and uses thereof

VEGF/DLL4 binding agents and uses thereof

Nucleic acid molecules encoding humanized IL-31 monoclonal antibodies

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

Human antibodies to Fel d1 and methods of use thereof

Anti-PHG-tau antibodies and their uses

Anti-N3pGlu amyloid beta peptide antibodies and uses thereof

Methods of Treating Inflammatory Pain

Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use

Method for obtaining information of test substance

Animal models and therapeutic molecules

PREVENTION AND TREATMENT OF PAIN USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID

Therapeutic antibodies and their uses

Human monoclonal antibody human CD134 (OX40) and methods of making and using same

Human CD30 Ligand Antigen Binding Proteins

Combination therapy for the treatment of cancer

Antibodies against TIM3 and uses thereof

Anti-ILT4 antibodies and antigen-binding fragments

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

Anti-nodal antibodies and methods of using same

Nucleic acids encoding chimeric and humanized anti-histone antibodies

Humanized monoclonal advanced glycation end-product antibody

Antibodies against F glycoprotein of Hendra and Nipah viruses

Methods and compositions related to functional polypeptides embedded in heterologous protein scaffolds

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Anti-podocalyxin antibodies and methods of using the same

Library of antigen-binding molecules including modified antibody variable region

Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate

High-throughput mouse model for optimizing antibody affinities

ANTI-CD47 ANTIBODIES AND METHODS OF USE THEREOF

Anti-CD47 antibodies and methods of use thereof

Bispecific CD33 and CD3 binding proteins

Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

Antibodies, binding fragments, and methods of use

Anti-Tie2 antibodies and uses thereof

HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR

SINGLE DOMAIN ANTIBODY AND DERIVATIVE PROTEINS THEREOF AGAINST PROGRAMMED DEATH-LIGAND (PDL1)

Humanized affinity matured anti-FcRn antibodies

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

ANTI-NRG1 (HEREGULIN) ANTIBODIES AND USES THEREOF

Methods of treatment using human anti-IL-23 antibodies

Compositions and methods for the depletion of CD137+ cells

METHODS OF TREATING INFLAMMATORY BOWEL DISEASE

Anti-PD-L1-anti-TIM-3 bispecific antibodies

Anti-ICOS agonist antibodies and uses thereof

ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TWO OR MORE ANTIGEN MOLECULES REPEATEDLY

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

Heterodimeric antibodies that bind CD3 and tumor antigens

PRODUCTION OF HETEROMULTIMERIC PROTEINS

ANTI-TFPI ANTIBODY VARIANTS WITH DIFFERENTIAL BINDING ACROSS PH RANGE FOR IMPROVED PHARMACOKINETICS

Bispecific antigen-binding constructs targeting Her2

ANTI-ErbB2 ANTIBODIES

Antigen-binding proteins that activate the leptin receptor

Antigen-binding proteins that activate the leptin receptor

Bispecific Constructs and Their Use in the Treatment of Various Diseases

PD-1 antibodies and uses thereof

ANTI-CD3XROB04 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Humanized anti-human CD19 antibodies and methods of use

Antibodies that bind human cannabinoid 1 (CB1) receptor

Cytoplasmic expression system

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

Broadly neutralizing antibody directed against HIV-1 GP140

Subcutaneous administration of antibody-drug conjugates for cancer therapy

Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Vantigen binding proteins exhibiting distinct binding characteristics

Antibodies targeting quiescin sulfhydryl oxidase (QSOX1) and uses of same

HER2 BINDING PROTEINS BASED ON DI-UBIQUITIN MUTEINS

Antigen-binding constructs targeting HER2

Antibody polypeptides and uses thereof

Antibodies specific for CLL-1

Antibodies which bind human glucagon receptor

Bispecific HER2 and CD3 binding molecules

CD3 binding polypeptides

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

Binding molecules specific for ASCT2 and uses thereof

Humanized or affinity-matured anti ang-2 antibody and uses thereof

Anti-C5a antibodies

Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51

Cell-based assay for detecting anti-CD3 homodimers

Anti-surrogate light chain antibodies

Antibodies and chimeric antigen receptors specific for ROR1

ANTAGONISTS OF PCSK9

Anti-sortilin antibodies and methods of use thereof

Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

Methods of treating cancer with a P2X7 peptide

Antibody to GDF8 and uses thereof

DNA molecules encoding antibodies to tau and methods of making thereof

Anti-PHF-tau antibodies and uses thereof

Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins

Antibodies specific to glycosylated BTLA (B- and T- lymphocyte attenuator)

T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA

Methods of using anti-phospholipase D4 antibodies

Anti-garp antibody

Humanized anti-TF-antigen antibodies

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

Anti-human 4-1BB antibodies and uses thereof

Method of treating IgA nephropathy by administering humanized APRIL-binding antibodies

Anti-CD115 antibodies

Antibodies to human erythroferrone and uses thereof

USE OF IL-1 BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE

Nucleic acids encoding IL-8 antibodies

CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES

HIV-1 neutralizing antibodies and uses thereof

Human endothelin receptor antibody and use thereof

METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE

PROTEASE-REGULATED ANTIBODIES

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat Hypoglycemia

Antibodies against canine PD-1

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Antibody therapeutics that bind TIM3

Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies

Mesothelin-targeted chimeric antigen receptors and methods of making them

Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE

POLYNUCLEOTIDES ENCODING MONOCLONAL ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F

Nucleic acids encoding IL-33 antibodies

Treating inflammation with IL-17/IL-23 bispecific antibodies

Human monoclonal antibodies against interleukin 8 (IL-8)

NOVEL ANTI-IL13 ANTIBODIES AND USES THEREOF

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

Synthetic antibodies to BAX and uses thereof

Composite comprising antibody capable of binding to intranuclear protein of influenza virus

Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

Anti-RSV monoclonal antibody formulation

MULTIMERIZATION TECHNOLOGIES

Bispecific antibody binding TRAIL-R2 and CD3

CD47 antibodies, methods, and uses

Human anti-VEGFR-2/KDR antibodies

Antibody to human and mouse SEMA3A and use thereof

Cytotoxicity-inducing therapeutic agent

Non-human animals that select for light chain variable regions that bind antigen

ANTIBODY OR ANTIBODY FRAGMENT OF NON-IG SCAFFOLD BINDING TO A BINDING REGION OF AN ANTI-N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTIBODY

Antibodies and assays for detection of CD37

Anti-GITR Antibodies and Methods of Use Thereof

Antibodies against human CSF-1R and uses thereof

ANTI-HUMAN CXCR3 ANTIBODIES FOR TREATMENT OF VITILIGO

ANTI-FGFR ANTIBODIES AND METHODS OF USE

VEGFR2 ANTIBODIES

Antibodies directed against ICOS and uses thereof

IMMUNOMODULATORY AGENTS

Novel Treatment Methods Based on Multifunctional Molecules

Antibody to human and mouse Sema3A and use thereof

Antibody to human and mouse SEMA3A and use thereof

Anti-PVRIG antibodies and methods of use

ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES

Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin Fc compositions with enhanced complement binding

Anti-IL31 antibodies for veterinary use

Anti-IL31 antibodies for veterinary use

Polynucleotides encoding anti-CXCL13 antibodies

Anti-TGF-β antibodies and their use

Dual PDGF/VEGF antagonists

Tetra-specific, octameric binding agents and antibodies against toxin A and toxin B for treatment of infection

Methods of generating antibodies

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

ANTI-VEGFR-2 UREASE CONJUGATES

Antibodies against LIF and uses thereof

Immunoassay for Collagen Type VIII Sequences

Methods for studying nucleic acids

MULTI-SPECIFIC MONOCLONAL ANTIBODIES

Specifically purified anti-presepsin antibody

CD73 blockade

PD-L1 antibodies binding canine PD-L1

ANTIBODIES AGAINST OX40 AND USES THEREOF

Humanized anti-CCR7 receptor antibodies

Method for expansion of a population of cells with IL2R beta/common gamma chain antibodies

Antibody fragments, compositions and uses thereof

Human CD3 binding antibody

Anti-αβTCR antibody

Anti-Aggrus monoclonal antibody, domain in Aggrus which is required for binding to CLEC-2, and method for screening for Aggrus-CLEC-2 binding inhibitor

Methods of diagnosing and treating hyperproliferative disorders

ANTIBODIES THAT RECOGNIZE IAPP

NOVEL MODULATORS AND METHODS OF USE

Multispecific binding molecules having specificity to dystroglycan and laminin-2

Single chain antibody domains for detection of anti-botulinum neurotoxin domains and methods of their use

Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120